Programmed cell death in spinal cord injury pathogenesis and therapy

Area of Science:

• Neuroscience
• Cell Biology
• Pathophysiology

Background:

• Spinal cord injury (SCI) results in functional decline, significantly influenced by cell death processes.
• Programmed cell death (PCD) is increasingly recognized as a critical mediator of secondary injury cascades following SCI.
• Various forms of PCD, including apoptosis, necroptosis, autophagy, ferroptosis, pyroptosis, and paraptosis, are implicated in SCI pathogenesis.

Purpose of the Study:

• To comprehensively review and elucidate the roles of diverse PCD modalities in the context of SCI.
• To enhance the understanding of the pathophysiological mechanisms underlying SCI.
• To identify potential therapeutic targets for improving functional outcomes after SCI.

Main Methods:

• Literature review synthesizing recent advancements in PCD research related to SCI.
• Analysis of experimental evidence detailing the involvement of specific PCD pathways (apoptosis, necroptosis, autophagy, ferroptosis, pyroptosis, paraptosis) in SCI models.
• Exploration of the molecular cascades and genetic events governing PCD after SCI.

Main Results:

• Programmed cell death, distinct from necrosis, is an active, genetically regulated process crucial for cellular homeostasis and defense.
• Specific PCD pathways are differentially activated following SCI, contributing to neuronal and glial cell loss.
• Characterization of these PCD mechanisms provides insights into the complex cellular responses to SCI.

Conclusions:

• Understanding the multifaceted roles of PCD in SCI is essential for deciphering its complex pathophysiology.
• Targeting specific PCD pathways holds promise for developing novel therapeutic strategies to mitigate secondary injury and promote neural repair.
• Further research into PCD mechanisms may illuminate the etiology of SCI and guide future treatment interventions.